Decode Health

The Decode Health team is excited to attend the 3686 conference, a leading event for entrepreneurs, investors, and tech innovators, on September 9-11, 2024, in Nashville, TN. Don’t miss the chance to connect with industry leaders shaping the next wave of healthcare and tech innovation - and be sure to check out the Climate Technologies panel moderated by Decode Health Co-Founder and Executive Advisor Julia Polk. See you at 3686! LaunchTN #3686fest #LaunchTN #entrepreneur #3686Conference #DecodeHealth #Innovation #Biotech #Biotechnology #Nashville #Tech #AI #ML #PrecisionMedicine

🚀 Recent AI and Biotechnology Developments 🚀 At Decode Health, we’re building the future of healthcare by empowering the industry with AI, machine learning, and analytics in population health and biomarker discovery. Here are some fascinating reads our team has been buzzing about: 1. AI-Driven Behavior Change is revolutionizing healthcare by leveraging personalization to improve daily habits. Thrive AI Health, backed by OpenAI and Thrive Global, is developing an AI health coach to provide personalized recommendations for better sleep, nutrition, exercise, and stress management. This AI aims to tackle chronic diseases by offering precise, actionable health advice tailored to individual needs. [via Sam Altman, Arianna Huffington, TIME] https://shorturl.at/vRCy0 2. Transcripta Bio is harnessing AI to transform drug discovery. By integrating machine learning with their Drug–Gene Atlas, they drastically reduce the time and cost of identifying new therapeutics. This approach has already uncovered several repurposing opportunities for rare diseases and aims to streamline the development of new treatments. [via Nature Portfolio] https://shorturl.at/APUzV 3. Profluent's AI Models are moving towards precise and steerable protein design. Their latest model, proseLM, incorporates structural and functional contexts into protein language models, enhancing gene editing activity and therapeutic antibody binding affinity. This advancement signifies a shift from discovery-based techniques to intentional design for tackling societal challenges. [via GEN Biotechnology] https://shorturl.at/Qh96o 4. AI and Gene Editing are setting new standards in biotech. Advances in AI's ability to design DNA and proteins, coupled with CRISPR technology, are enabling scientists to create bespoke proteins for various applications, from reducing greenhouse gases to developing new medical treatments. This synergy between AI and gene editing promises a significant leap forward in biotechnology. [via SingularityHub] https://shorturl.at/rXmvJ 5. Reforming the NIH is critical for maintaining America's leadership in biomedical research. Proposed structural reforms aim to streamline the NIH’s 27 Institutes and Centers into 15, fostering a more integrated and agile approach to scientific research. This restructuring is essential for addressing current scientific challenges and ensuring the NIH's mission aligns with future needs. [via House Committee on Energy and Commerce] https://shorturl.at/AaWba 6. AI Regional Centers are essential for evaluating the clinical effectiveness of AI in healthcare. There is a pressing need for real-world evaluations of AI models to ensure they improve patient outcomes. The establishment of AI Implementation Centers is proposed to bridge this gap, focusing on local context and integration into clinical workflows. [via NEJM Group AI] https://lnkd.in/e4n2mF83 #AI #Healthcare #Biotechnology #DrugDiscovery #Genomics #PersonalizedMedicine

Transforming healthcare with AI? Check out our latest article on the Coalition for Health AI (CHAI) Assurance Standards and how they guide responsible AI in healthcare. The themes captured in the report are woven into the fabric of Decode Health and how we apply advanced data techniques to accelerate precision medicine efforts alongside our partners and contribute to Nashville's thriving innovation ecosystem. Dive into the future of safe, secure, equitable, and innovative approaches that will improve health and health outcomes. #AI #MachineLearning #HealthcareStandards #AIEthics #HealthTech #PatientSafety Read more:

At Decode Health, we often leverage publicly available genomics databases to accelerate and de-risk biomarker discovery initiatives. Check out our latest article, "The Power of Publicly Available Genomics Databases in Biomarker Discovery," to learn how public genomics data can transform diagnostics, therapeutics, and precision medicine. #Genomics #AI #ArtificialIntelligence #ML #MachineLearning #Biotech #Biotechnology #Pharma #DrugDiscovery #PrecisionMedicine #DecodeHealth

Our recent webinar on RNA biomarker discovery was a success! 🎉 Thank you to everyone who joined us and contributed to the engaging discussion. For those who couldn't join the live session, we have made the recording available. Learn from experts Cheryl Sesler, MS (Decode Health), and Dr. Annika Dorn (Agilent Technologies) as they discuss the importance of sample quality control and the need for a robust QC framework in RNA biomarker discovery. Discover how RNA sequencing unlocks promising biomarkers and how robust QC practices can minimize reproducibility challenges. Watch the recording here: https://lnkd.in/eXZaA7ZC #RNABiomarkers #NGS #QualityControl #BiomarkerDiscovery #RNASeq #RNASequencing #Research #AgilentTechnologies #DecodeHealth #Webinar #LifeSciences #Bioinformatics

The Decode Health team was thrilled to attend last week's inaugural Biotech Day Summit, hosted by Phase Capital and 615.vc. Over 150 biotech startups, investors, academic leaders, and strategic partners representing 13 states joined for the day's activities. Our CEO, Dr. Chase Spurlock, moderated a panel - the "Role of AI in Revolutionizing Biotech and Healthcare" with Dr. Shakthi Kumar and representatives from Minnow Ventures (Maya Frutiger), HistAI (Katherine I.), and First Ascent Biomedical (Noah Berlow). In a wide-ranging conversation, the panel discussed approaches to vet new AI-enabled companies and efficiently leverage AI tools and emerging technologies, including quantum computing, to accelerate new discoveries. A special thank you to Kavya Sharman, PhD and Oliver Muoto for bringing everyone together. #NashvilleBioTech #Genomics #MachineLearning #AI #Healthcare

We’re excited to partner with Agilent Technologies to present Decode Health’s RNA biomarker discovery framework to uncover reliable biomarkers to detect, monitor, and treat disease. This webinar will discuss implementing a multifaceted quality control plan to optimize your design and boost confidence in your findings. Please join Cheryl Sesler, MS, Associate Director of Research at Decode, and Dr. Annika Dorn at Agilent by registering at the link below! Tuesday, June 18 at 11:00AM EST Link to register: https://bit.ly/3UB3MkK #RNAsequencing #RNAseq #BiomarkerDiscovery #Transcriptomics #Diagnostics #Therapeutics #Biomarkers #NextGenSequencing #QualityControl #webinar

The Decode Health team was thrilled to present our latest research at CMSC 2024 in our home city of #Nashville! We connected with #multiplesclerosis experts and pharmaceutical, medical device, and technology companies from across the country. Highlights included presentations by Lukasz Wylezinski, Cheryl Sesler, and Chase Spurlock and an inspiring President’s Lecture by Dr. Fred Lubin (Mount Sinai Health System). It was a fantastic opportunity to engage with the MS research community and explore new advancements in MS and other neuroinflammatory conditions. Key messages emphasized: ·      The differential diagnosis of MS and subsequent monitoring of progression and disease activity remains challenging. ·      The convergence of multi-modal data, including MRI, liquid biopsy, pathology, and genetics, will improve MS care management. ·      Adopting artificial intelligence (AI) for precision medicine is imminent, and clinicians should consider how AI will support their clinical practice. ·      AI-enabled solutions have directly enhanced screening and analysis of MRI results and are just the tip of the iceberg for advancing the diagnosis and monitoring of MS. ·      Biomarkers, such as NfL and GFAP, are promising blood-based biomarkers for assessing neurodegeneration and influencing therapy. MS-specific biomarkers for monitoring disease activity and progression would be ideal. #CMSC2024 #CMSC #MS #MultipleSclerosis #NMO #NeuromyelitisOptica #TeamOscar

The Decode Health team is proud to present three new abstracts at CMSC 2024 in Nashville. Please swing by the poster session on Thursday, May 30, from 5-7 pm at the Nashville Music City Center. To learn more, click on the article below to dive into our latest research, combining machine learning, RNA sequencing, and predictive analytics in multiple sclerosis and neuromyelitis optica. #CMSC #CMSC2024 #MS #MultipleSclerosis #NMO #NeuromyelitisOptica #MachineLearning #PrecisionMedicine #RNASequencing

Our latest article explores how AI is revolutionizing the pharmaceutical industry and how Decode Health is leveraging its capabilities to advance precision medicine and enhance patient outcomes. Inspired by an article from Nick Wichert of High Alpha Innovation. #AI #ArtificialIntelligence #MachineLearning #MolecularDiagnostics #Biotech #Biotechnology #Pharma #Pharmaceutical